Insider · CIK 0002045159
Franziska Michor
director
Files at RXRX (RECURSION PHARMACEUTICALS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Class A Common Stock | +22,016 | $0.00 | $0 | 127,053 | Jun 23, 2025 |
| Jun 18, 2025 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +44,031 | $0.00 | $0 | 44,031 | Jun 23, 2025 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Class A Common Stock | +30,618 | - | - | 30,618 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Class A Common Stock | +15,335 | $0.00 | $0 | 45,953 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Class A Common Stock | +17,694 | $0.00 | $0 | 63,647 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Class A Common Stock | +41,390 | $0.00 | $0 | 105,037 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +30,670 | - | - | 30,670 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +15,286 | - | - | 15,286 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +17,694 | - | - | 17,694 | Nov 22, 2024 |
| Nov 20, 2024 | RXRX RECURSION PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +82,781 | $0.00 | $0 | 82,781 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.